Abstract
Introduction: Urinary tract infections (UTI) are one of the most common infectious diseases. In a limited resource setting, the availability of and accessibility to the new generation higher antibiotics is always a cause for concern. this study was conducted in patients with uncomplicated UTIs to evaluate the microbial growth pattern obtained from the urine specimens and their corresponding antibiotic sensitivity profile using conventional antibiotics
Materials and Methods: A prospective cross sectional study was conducted in a Government Medical College in Chennai comprising of 296 patients with clinically suspected UTI. Urine samples were collected and subjected to standard culture and sensitivity testing. SPSS software (version 16) was used to analyse the data. Simple descriptive statistics, Kruskal Wallis test and Man Whitney U post hoc tests were carried out. P<0.05 was considered significant.
Results: E.coli was the most common organism isolated in 66 out of total 296 samples (22.3%), followed by Enterobacter (2.7%). For E.coli, Amikacin was the drug to which most cultures (62.1%) were sensitive, followed by Cotrimoxazole (31.8%) and Nitrofurantoin (25.8%). For Enterobacter species, Gentamycin, Amikacin and Nitrofurantoin were equally sensitive (50%)
Conclusion: E.Coli is responsible for a vast majority of UTI and that Amikacin can be used as an empirical first line antibiotic for UTI in males and females in a limited resource setting where higher and newer antibiotics are not available
Keywords: UTI, E.coli, Amikacin.
References
- Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. The Journal of infectious diseases. 2001;183(Supplement_1):S1-S4.
- Hooton TM. Uncomplicated urinary tract infection. New England Journal of Medicine. 2012;366(11):1028-37.
- Grabe M, Bartoletti R, Bjerklund-Johansen T. Guidelines on urological infections. European Association of Urology Web site. 2015.
- Nicolle LE. Urinary tract infection. Critical care clinics. 2013;29(3):699-715.
- Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infectious disease clinics of North America. 2014;28(1):1-13.
- Hummers-Pradier E, Ohse A, Koch M, Heizmann W, Kochen M. Urinary tract infection in men. International journal of clinical pharmacology and therapeutics. 2004;42(7):360-6.
- Patel S, Taviad PP, Sinha M, Javadekar T, Chaudhari VP. Urinary tract infections (UTI) among patients at GG hospital & medical college, jamnagar. National Jou-rnal of Community Medicine. 2012;3(1): 138-41.
- Chenoweth C, Saint S. Preventing catheter-associated urinary tract infections in the intensive care unit. Critical care clinics. 2013;29(1):19-32.
- Tuli L, Rai S, Arif D, Singh DK. Bacteriological profile and Antimicrobial Susceptibility pattern of isolates from Urinary Tract Infections in Eastern Uttar Pradesh, India. Int J Curr Microbiol App Sci. 2016;5(3):428-35.
- Sorlozano A, Jimenez-Pacheco A, Del Castillo JdDL, Sampedro A, Martinez-Brocal A, Miranda-Casas C, et al. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study. American journal of infection control. 2014;42(10):1033-8.
- Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. The Indian journal of medical research. 2014;139(6):945.
- Prakash D, Saxena R. Prevalence and antimicrobial susceptibility pattern of Escherichia coli in hospital acquired and community acquired patients related to urinary tract infection in India. 2013.
- Ahmed SM, JAKRIBETTU RP, KOYAKUTTY S, Arya B, Shakir V. Urinary Tract Infections-An overview on the Prevalence and the Anti-biogram of Gram Negative Uropathogens in A Tertiary Care Centre in North Kerala, India. Journal of Clinical & Diagnostic Research. 2012;6(7).
- Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009). BMC infectious diseases. 2013;13(1):19.
- Gupta K, Bhadelia N. Management of urinary tract infections from multidrug-resistant organisms. Infectious Disease Clinics. 2014;28(1):49-59.